GM

Gisela Mautner

Noxopharm Limited | Chief Executive Officer, Managing Director
Ms Mautner is an international business leader with experience in developing and launching new pharmaceutical products and delivering corporate strategies in highly competitive global markets. Gisela has held senior positions with Amgen, Bayer, Siemens Medical Solutions and Merck/MSD generating commercial and scientific outcomes. She is currently the Past-President of the Medical Affairs Professionals Association of Australasia (MAPA) and a Member of the Australian Institute of Company Directors and the CEO Institute. She is also a Non-executive Director of a not-for-profit organization.

Companies and Roles

Company
Title
Tenure
Since
NOX
Noxopharm Limited
  • Chief Executive Officer
  • Managing Director
3yrs, 2mthFeb 2022
NYR
Nyrada Inc
  • Non-Executive Director
2yrs, 8mthAug 2022

Holdings

Company
Last Notice
Direct Shares
Indirect Shares
Options
Convertibles
NYR
Nyrada Inc
12/11/240N/A1,800,000N/A
NOX
Noxopharm Limited
30/06/24N/AN/A2,135,000N/A

Transactions

Company
Date
Type
Amount
Price
Value
Notes
NYR
Nyrada Inc
12/11/24
Issued
1,800,000$0.110$198,000Director remuneration